This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sustained incobotulinumtoxinA (Xeomin) efficacy in upper limb poststroke spasticity over 48 weeks in A phase 3, placebo-controlled study with an open-label extension. (25th December 2016)
Record Type:
Journal Article
Title:
Sustained incobotulinumtoxinA (Xeomin) efficacy in upper limb poststroke spasticity over 48 weeks in A phase 3, placebo-controlled study with an open-label extension. (25th December 2016)
Main Title:
Sustained incobotulinumtoxinA (Xeomin) efficacy in upper limb poststroke spasticity over 48 weeks in A phase 3, placebo-controlled study with an open-label extension